What is Next-Chemx Corp's earnings per share (EPS)?

Next-Chemx Corp (CHMX) reported diluted earnings per share of $-0.06 for fiscal year 2024. This represents a 33.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Next-Chemx Corp Financials

CHMX

Source SEC Filings (10-K/10-Q) Updated Jun 30, 2025 Currency USD FYE December

This page shows Next-Chemx Corp (CHMX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CHMX FY2024 2026-04-22

External financing remains the core operating mechanic as negative equity and thin liquidity prevent the business from self-funding.

Cash dependence is deeper than the income statement suggests: the latest year used -$1.5M in operating cash flow while raising $1.6M from financing, so routine activity was effectively funded from outside the business. Even though net loss narrowed from -$2.5M to -$1.8M, cash burn worsened, which points to weaker earnings quality rather than a clean operating recovery.

Balance-sheet strain looks structural: liabilities of $6.2M sit against assets of $3.3M, making the company more dependent on creditors and fresh capital than on accumulated equity. Negative equity means past losses have already consumed the book capital base, so new funding can sustain operations without materially repairing solvency.

Liquidity improved but remains tight; the current ratio moved from 0.04x to 0.2x, which is progress but still far below a comfortable short-term cushion. Cash increased from $2K to $63K, yet that gain is small beside the current liability load, so working capital still behaves like a constraint rather than a buffer.

Financial Health Signals

Financial Profile 5/100

Based on FY2024 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Next-Chemx Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

Next-Chemx Corp has a moderate D/E ratio of -2.12. This balance of debt and equity financing earns a leverage score of 33/100.

Liquidity

Next-Chemx Corp's current ratio of 0.15 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Piotroski F-Score Neutral

4/9

Next-Chemx Corp passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass.

Earnings Quality Low Quality

0.84x

For every $1 of reported earnings, Next-Chemx Corp generates $0.84 in operating cash flow (-$1.5M OCF vs -$1.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-9.3x

Next-Chemx Corp earns $-9.3 in operating income for every $1 of interest expense (-$1.7M vs $187K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

-$1.6M

YoY+19.9%

Next-Chemx Corp's EBITDA was -$1.6M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 19.9% from the prior year.

Net Income

-$1.8M

YoY+27.7%

Next-Chemx Corp reported -$1.8M in net income in fiscal year 2024. This represents an increase of 27.7% from the prior year.

EPS (Diluted)

$-0.06

YoY+33.3%

Next-Chemx Corp earned $-0.06 per diluted share (EPS) in fiscal year 2024. This represents an increase of 33.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$63K

YoY+2444.6%

5Y CAGR+156.2%

Next-Chemx Corp held $63K in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

29M

YoY+0.0%

Next-Chemx Corp had 29M shares outstanding in fiscal year 2024. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

CHMX Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	N/A	N/A	N/A	N/A	N/A	$1K
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	$1K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$8K-99.6%	$2.0M+18.1%	$1.7M-5.3%	$1.8M+1393.7%	$118K+15.4%	$102K
Operating Income	-$1.7M+18.4%	-$2.1M-27.1%	-$1.7M+5.3%	-$1.8M-1393.7%	-$118K-17.1%	-$101K
Interest Expense	$187K+112.9%	$88K+24.3%	$71K+111.3%	$33K	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$1.8M+27.7%	-$2.5M-44.0%	-$1.7M+2.3%	-$1.8M	N/A	-$140K
EPS (Diluted)	$-0.06+33.3%	$-0.09-50.0%	$-0.06	N/A	N/A	N/A

Metric	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	$319K-11.8%	$362K-24.9%	$482K	N/A	$403K
Operating Income	-$392K+5.6%	-$415K	N/A	-$330K+25.2%	-$440K+15.3%	-$520K	N/A	-$403K
Interest Expense	$70K+9.9%	$64K	N/A	$49K+17.6%	$42K+14.2%	$37K	N/A	$19K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$456K+2.2%	-$466K	N/A	-$380K+0.8%	-$383K+31.1%	-$556K	N/A	-$923K
EPS (Diluted)	$-0.020.0%	$-0.02	N/A	$-0.010.0%	$-0.01+50.0%	$-0.02	N/A	$-0.03

CHMX Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$3.3M+14.4%	$2.8M-11.6%	$3.2M+1.1%	$3.2M+6708.4%	$47K-90.9%	$515K
Current Assets	$706K+402.8%	$140K+177.7%	$51K+320.0%	$12K-74.3%	$47K-90.9%	$515K
Cash & Equivalents	$63K+2444.6%	$2K-91.3%	$28K+171.9%	$10K-76.6%	$45K+7769.3%	$567
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$6.2M+56.6%	$3.9M+58.1%	$2.5M+69.0%	$1.5M+631.3%	$201K-69.8%	$667K
Current Liabilities	$4.6M+16.3%	$3.9M+58.1%	$2.5M+69.0%	$1.5M+631.3%	$201K-69.8%	$667K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$2.9M-166.8%	-$1.1M-248.6%	$732K-57.3%	$1.7M+1209.1%	-$154K-1.7%	-$152K
Retained Earnings	-$8.3M-27.9%	-$6.5M-76.3%	-$3.7M-89.5%	-$1.9M-1084.3%	-$165K+41.8%	-$283K

Metric	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$3.2M-0.2%	$3.2M-2.4%	$3.3M-0.9%	$3.3M+1.2%	$3.2M+12.5%	$2.9M+1.3%	$2.8M-16.3%	$3.4M
Current Assets	$698K+5.0%	$665K-5.8%	$706K+1.6%	$695K+12.6%	$617K+184.5%	$217K+54.5%	$140K-40.4%	$235K
Cash & Equivalents	$22K+3501.5%	$612-99.0%	$63K+76.8%	$35K+5006.2%	$693-99.3%	$95K+3755.6%	$2K-96.0%	$61K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	$496K+27.0%	$391K	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$7.0M+6.9%	$6.5M+6.3%	$6.2M+8.2%	$5.7M+8.0%	$5.3M+16.5%	$4.5M+15.1%	$3.9M+14.1%	$3.4M
Current Liabilities	$4.9M+2.1%	$4.8M+5.3%	$4.6M+2.3%	$4.5M+5.0%	$4.3M+2.3%	$4.2M+5.8%	$3.9M+14.1%	$3.4M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$3.8M-13.5%	-$3.4M-16.1%	-$2.9M-20.5%	-$2.4M-18.8%	-$2.0M-23.3%	-$1.6M-51.2%	-$1.1M-2229.4%	-$47K
Retained Earnings	-$9.2M-5.2%	-$8.8M-5.6%	-$8.3M-6.3%	-$7.8M-5.1%	-$7.5M-5.4%	-$7.1M-8.5%	-$6.5M-19.0%	-$5.5M

CHMX Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	-$1.5M-181.3%	-$545K+41.7%	-$935K-32.9%	-$704K-483.4%	$183K-51.3%	$377K
Capital Expenditures	N/A	N/A	$2K-93.4%	$24K	N/A	N/A
Free Cash Flow	N/A	N/A	-$937K-28.7%	-$728K	N/A	N/A
Investing Cash Flow	N/A	N/A	-$2K+93.4%	-$24K-2412.5%	$1K	N/A
Financing Cash Flow	$1.6M+206.9%	$519K-45.6%	$955K+37.7%	$693K+9943.8%	-$7K+71.3%	-$25K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	-$329K-58.8%	-$207K+58.6%	-$500K-191.8%	-$171K+69.9%	-$569K-94.4%	-$293K-64.0%	-$178K+9.3%	-$197K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$350K+141.4%	$145K-72.5%	$527K+155.8%	$206K-56.6%	$475K+23.4%	$385K+220.8%	$120K-40.0%	$200K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

CHMX Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A	100.0%
Operating Margin	N/A	N/A	N/A	N/A	N/A	-7070.4%
Net Margin	N/A	N/A	N/A	N/A	N/A	-9783.7%
Return on Equity	N/A	N/A	-238.3%-134.1pp	-104.2%	N/A	N/A
Return on Assets	-55.7%+32.5pp	-88.3%-34.1pp	-54.2%+1.9pp	-56.0%	N/A	-27.1%
Current Ratio	0.15+0.1	0.04+0.0	0.02+0.0	0.01-0.2	0.23-0.5	0.77
Debt-to-Equity	-2.12+1.5	-3.62-7.0	3.40+2.5	0.86+2.2	-1.30+3.1	-4.39
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-14.4%+0.3pp	-14.7%	N/A	-11.6%+0.2pp	-11.8%+7.5pp	-19.3%	N/A	-27.2%
Current Ratio	0.140.0	0.14-0.0	0.150.0	0.16+0.0	0.14+0.1	0.05+0.0	0.04-0.0	0.07
Debt-to-Equity	-1.83+0.1	-1.94+0.2	-2.12+0.2	-2.36+0.2	-2.60+0.2	-2.75+0.9	-3.62+70.2	-73.81
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$2.9M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.15), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Crawford United CRAWA

$292.8M

$50.9M

$200.6M

$433.8M

$453.4M

Frequently Asked Questions

Is Next-Chemx Corp profitable?

No, Next-Chemx Corp (CHMX) reported a net income of -$1.8M in fiscal year 2024.

What is Next-Chemx Corp's EBITDA?

Next-Chemx Corp (CHMX) had EBITDA of -$1.6M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is Next-Chemx Corp's operating cash flow?

Next-Chemx Corp (CHMX) generated -$1.5M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Next-Chemx Corp's total assets?

Next-Chemx Corp (CHMX) had $3.3M in total assets as of fiscal year 2024, including both current and long-term assets.

How many shares does Next-Chemx Corp have outstanding?

Next-Chemx Corp (CHMX) had 29M shares outstanding as of fiscal year 2024.

What is Next-Chemx Corp's current ratio?

Next-Chemx Corp (CHMX) had a current ratio of 0.15 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

What is Next-Chemx Corp's debt-to-equity ratio?

Next-Chemx Corp (CHMX) had a debt-to-equity ratio of -2.12 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Next-Chemx Corp's return on assets (ROA)?

Next-Chemx Corp (CHMX) had a return on assets of -55.7% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Next-Chemx Corp's cash runway?

Based on fiscal year 2024 data, Next-Chemx Corp (CHMX) had $63K in cash against an annual operating cash burn of $1.5M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Next-Chemx Corp's debt-to-equity ratio negative or unusual?

Next-Chemx Corp (CHMX) has negative shareholder equity of -$2.9M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Next-Chemx Corp's Piotroski F-Score?

Next-Chemx Corp (CHMX) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Next-Chemx Corp's earnings high quality?

Next-Chemx Corp (CHMX) has an earnings quality ratio of 0.84x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Next-Chemx Corp cover its interest payments?

Next-Chemx Corp (CHMX) has an interest coverage ratio of -9.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Next-Chemx Corp?

Next-Chemx Corp (CHMX) scores 5 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.